Muriel Elhaï

Mapping and predicting mortality from systemic sclerosis

Muriel Elhaï, Christophe Meune, Marouane Boubaya et al. · Annals of the Rheumatic Diseases · 2017 · 684 citations · Full text

Public Health, Biostatistics, Clinical Epidemiology +16

Outcomes of patients with systemic sclerosis-associated polyarthritis and myopathy treated with tocilizumab or abatacept: a EUSTAR observational study

Muriel Elhaï, Marine Meunier, Marco Matucci‐Cerinic et al. · Annals of the Rheumatic Diseases · 2012 · 189 citations

Life Sciences, Immunology, Pharmacotherapy +16

Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study

Muriel Elhaï, Marouane Boubaya, Oliver Distler et al. · Annals of the Rheumatic Diseases · 2019 · 188 citations · Full text

Medicine, Immunology, Pharmacotherapy +14

Performance of Candidate Serum Biomarkers for Systemic Sclerosis–Associated Interstitial Lung Disease

Muriel Elhaï, Anna‐Maria Hoffmann‐Vold, Jérôme Avouac et al. · Arthritis & Rheumatology · 2019 · 137 citations · Full text

Medicine, Pathology, Immunopathology +16

A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study

Muriel Elhaï, Jérôme Avouac, Ulrich A. Walker et al. · Annals of the Rheumatic Diseases · 2014 · 106 citations

Life Sciences, Biostatistics, Cardiology +17